We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSBC icon
3076
WesBanco
WSBC
$4B
$5K ﹤0.01%
+114
New +$4.26K
SUNE
3077
SUNation Energy
SUNE
$10.8M
0
FFNW
3078
DELISTED
First Financial Northwest, Inc
FFNW
$5K ﹤0.01%
+237
New +$3.89K
ENZ
3079
DELISTED
Enzo Biochem, Inc.
ENZ
$5K ﹤0.01%
718
-708
-50% -$4.52K
IVAC
3080
DELISTED
Intevac Inc
IVAC
$5K ﹤0.01%
588
+453
+336% +$2.85K
AGR
3081
DELISTED
Avangrid, Inc.
AGR
$5K ﹤0.01%
+130
New +$4.96K
SPWR
3082
DELISTED
SunPower Corporation Common Stock
SPWR
$5K ﹤0.01%
1,055
-13,566
-93% -$66.4K
HEWG
3083
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$5K ﹤0.01%
175
+75
+75% +$1.83K
MCBC
3084
DELISTED
Macatawa Bank Corp
MCBC
$5K ﹤0.01%
+500
New +$4.49K
AINC
3085
DELISTED
Ashford Inc.
AINC
$5K ﹤0.01%
+114
New +$4.98K
DLA
3086
DELISTED
Delta Apparel Inc.
DLA
$5K ﹤0.01%
225
-1,530
-87% -$27.7K
NBSE
3087
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$5K ﹤0.01%
+9
New +$9.51K
PATI
3088
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$5K ﹤0.01%
249
-48
-16% -$1.08K
FRBK
3089
DELISTED
Republic First Bancorp Inc
FRBK
$5K ﹤0.01%
+631
New +$3.49K
PTNR
3090
DELISTED
Partner Communications
PTNR
$5K ﹤0.01%
1,072
+123
+13% +$571
TTM
3091
DELISTED
Tata Motors Limited
TTM
$5K ﹤0.01%
137
-11,160
-99% -$412K
MNDT
3092
DELISTED
Mandiant, Inc. Common Stock
MNDT
$5K ﹤0.01%
430
-1,508
-78% -$19.6K
JMP
3093
DELISTED
JMP Group LLC
JMP
$5K ﹤0.01%
+758
New +$4.47K
GMLP
3094
DELISTED
Golar LNG Partners LP
GMLP
$5K ﹤0.01%
+209
New +$4.45K
TCO
3095
DELISTED
Taubman Centers Inc.
TCO
$5K ﹤0.01%
77
-4,200
-98% -$305K
BSTC
3096
DELISTED
BioSpecifics Technologies Corp.
BSTC
$5K ﹤0.01%
100
-165
-62% -$7.93K
STPP
3097
DELISTED
iPath US Treasury Steepener ETN
STPP
$5K ﹤0.01%
156
-510
-77% -$17K
STML
3098
DELISTED
Stemline Therapeutics, Inc.
STML
$5K ﹤0.01%
+457
New +$5.53K
FTEO
3099
DELISTED
FRONTEO, Inc. American Depositary Shares
FTEO
$5K ﹤0.01%
355
-682
-66% -$11K
ARQL
3100
DELISTED
Arqule Inc
ARQL
$5K ﹤0.01%
+4,108
New +$5.74K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.